6.4305 - 7.23
5.68 - 48.32
Join Discuss about DMTK with like-minded investors
Dmtk down 13% all Lupton followers now big underwater
51 Replies 14 👍 13 🔥
Next Dividend Date
DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform dermatology with its non-invasive skin genomics platform, to democratize access to high quality dermatology care, and to improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments.